Skip to main content
Clinical Trials/NCT03745118
NCT03745118
Completed
Not Applicable

Development of a Practical, Minimally Invasive Seizure Gauge

Mayo Clinic1 site in 1 country95 target enrollmentNovember 19, 2018
ConditionsEpilepsy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Epilepsy
Sponsor
Mayo Clinic
Enrollment
95
Locations
1
Primary Endpoint
Pattern Analysis
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The researchers are trying to assess changes in physiological signals before and during seizures.

Detailed Description

Subjects that are undergoing video EEG monitoring in the hospital for their epilepsy at Mayo Clinic will be consented to participate in this study for a minimum of two days and/or the duration of their hospital stay for their clinical care. Subjects will be asked to wear up to 4 different commercially available seizure detection devices and complete surveys. In the second year of the study patients who have implanted devices capable of recording or detecting seizures will be recruited to wear a noninvasive biosensor for multiple months. This data will be used to develop algorithms capable of detecting and/or forecasting seizures. When the subjects clinical EEG monitoring is completed data scientists will analyze the data to identify patterns.

Registry
clinicaltrials.gov
Start Date
November 19, 2018
End Date
August 5, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Benjamin H. Brinkmann

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Patients with epilepsy- scalp EEG or invasive EEG monitoring for clinical care, or an implanted device capable of monitoring brain activity and identifying seizures (e.g. NeuroPace RNS, Medtronic PC+S, Medtronic RC+S)
  • Pediatric subjects 7 years of age or older.

Exclusion Criteria

  • Cognitive or psychiatric condition rendering patient unable to cooperate with data collection, or manage and recharge smart watch and tablet computer devices.
  • Presence of open or healing wounds near monitoring sites (infection risk).

Outcomes

Primary Outcomes

Pattern Analysis

Time Frame: 2-10 days approximately

We will apply data mining and machine learning methods to search for patterns in the collected physiological signals and correlate these patterns with the timing of seizures identified by the patient's clinical video-EEG monitoring.

Assessment of Physiological Signals Measurable with Wearable Sensors

Time Frame: 2-10 days approximately

We will collect physiological signals with the five wearable, noninvasive biosensors listed below in Mayo patients undergoing scalp-recorded video EEG and invasive stereotactic EEG/video monitoring as part of their clinical epilepsy evaluation. We will evaluate biosignals based on data quality and reliability, and subject comfort and ease of use.

Study Sites (1)

Loading locations...

Similar Trials